I think the company would explain the large rise in gross margin as being a consequence of the change in sales mix. The high margin EZZ brand made up 88% of revenue in FY23 but only 54% of the revenue in FY22. The third party brand EAORON has margins in the 20 - 30% range and these sales have declined in FY23 due to a refresh of the product lines. The EZZ brand itself may have experienced higher margins in FY23 on the back of greater volume, I would assume.
One thing that has caught my eye is that Vita Life Science (VLS) also called out surging vitamin sales into China from Australia this calendar year, up about 33% and not a dissimilar figure to EZZ's sales growth. Let's hope it continues!
- Forums
- ASX - By Stock
- EZZ
- Ann: Preliminary Final Report
Ann: Preliminary Final Report, page-20
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EZZ (ASX) to my watchlist
|
|||||
Last
$2.90 |
Change
0.240(9.02%) |
Mkt cap ! $128.7M |
Open | High | Low | Value | Volume |
$2.71 | $3.00 | $2.70 | $749.7K | 261.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 994 | $2.86 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.90 | 11625 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 994 | 2.860 |
1 | 2000 | 2.850 |
1 | 3000 | 2.760 |
1 | 182 | 2.750 |
1 | 3000 | 2.740 |
Price($) | Vol. | No. |
---|---|---|
2.900 | 11625 | 2 |
2.950 | 10000 | 1 |
2.980 | 4000 | 1 |
2.990 | 7173 | 2 |
3.000 | 9520 | 2 |
Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
Featured News
EZZ (ASX) Chart |